Somatic Mutations and Splicing Variants of Focal Adhesion Kinase in Non-Small Cell Lung Cancer

Bo Zhou1, Gui-Zhen Wang1, Zhe-Sheng Wen2

  • 1State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences and University of Chinese Academy of Sciences, Beijing, China.

Abstract

Insights

Focal adhesion kinase (FAK) mutations and splicing variants are found in lung cancer, particularly in smokers. These FAK alterations enhance kinase activity and sensitivity to inhibitors, suggesting potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Focal adhesion kinase (FAK) overexpression is noted in lung cancer.
  • Somatic mutations and alternative splicing of FAK are not well-understood in lung cancer.

Purpose of the Study:

  • Investigate somatic mutations and alternative splicing variants of FAK in lung cancer.
  • Analyze the functional impact and therapeutic potential of FAK alterations.

Main Methods:

  • Sequenced FAK in 91 lung cancer patients using tumor and normal tissues.
  • Analyzed TCGA RNA-seq data for FAK variants.
  • Assessed biological functions and inhibitor response of FAK variants in cell lines.

Main Results:

  • Identified FAK internal tandem duplication (ITD), A1004S mutation, exon 5-27 deletion, and FAK6,7 splicing variants in 7.7% of patients.
  • FAK alterations were more prevalent in smokers.
  • FAK-ITD and FAK6,7 variants showed increased autophosphorylation and sensitivity to FAK inhibitors, promoting cell proliferation and migration.

Conclusions:

  • Somatic mutations and splicing variants of FAK play a role in lung carcinogenesis.
  • FAK alterations represent potential biomarkers for FAK-targeted therapies in lung cancer.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.8K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K